Not logged in A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC) Aroldi, Francesca; Elez, Elena; Andre, Thierry; Perkins, Geraldine; Prenen, Hans; Popovici, Vlad; Gallagher, Peter; Houlden, Jennifer; Collins, Linda; Roberts, Corran; Rolfo, Christian; Di Nicolantonio, Federica; Grayson, Margaret; Boyd, Ruth; Bettens, Karolien; Delfavero, Jurgen; Coyle, Victoria; Lawler, Mark; Khawaja, Hajrah; Laurent-Puig, Pierre; Salto-Tellez, Manuel; Maughan, Tim S.; Tabernero, Josep; Adams, Richard; Jones, Robert; Hennessy, Bryan T.; Bardelli, Alberto; Peeters, Marc; Middleton, Mark R.; Wilson, Richard H.; Van Schaeybroeck, Sandra Share Save
Share Save
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer Nicum, Shibani; Mcgregor, Naomi; Austin, Rachel; Collins, Linda; Dutton, Susan; Mcneish, Iain; Glasspool, Rosalind; Hall, Marcia; Roux, Rene; Michael, Agnieszka; Clamp, Andrew; Jayson, Gordon; Kristeleit, Rebecca; Banerjee, Susana; Mansouri, Anita Share Save
Three-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase III trial Piperno-Neumann, S.; Hassel, J. C.; Rutkowski, P.; Baurain, J. F.; Schlaak, M.; Butler, M. O.; Sullivan, R. J.; Dummer, R.; Kirkwood, J. M.; Orloff, M.; Sacco, J. J.; Ochsenreither, S.; Joshua, A. M.; Gastaud, L.; Curti, B.; Carvajal, R. D.; Hamid, O.; Collins, L.; Holland, C.; Nathan, P. Share Save
Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound Spiers, Laura; Gray, Michael; Lyon, Paul; Sivakumar, Shivan; Bekkali, Noor; Scott, Shaun; Collins, Linda; Carlisle, Robert; Wu, Feng; Middleton, Mark; Coussios, Constantin Share Save
Randomised phase II trial of olaparib compared to weekly paclitaxel or olaparib plus cediranib in patients with platinum-resistant ovarian cancer (OCTOVA) Nicum, S.; Holmes, J.; McGregor, N.; Dunn, R.; Collins, L.; Kaye, S.; McNeish, I.; Glasspool, R. M.; Hall, M.; Roux, R.; Michael, A.; Banerjee, S.; Kristeleit, R.; Jayson, G.; Clamp, A.; Mansouri, A. Share Save
Share Save
Share Save
Share Save
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma Thomas, Anne; Virdee, Pradeep S.; Eatock, Martin; Lord, Simon R.; Falk, Stephen; Anthoney, D. Alan; Turkington, Richard C.; Goff, Matthew; Elhussein, Leena; Collins, Linda; Love, Sharon; Moschandreas, Joanna; Middleton, Mark R. Share Save
Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma Gupta, Avinash; Towers, Christopher; Willenbrock, Frances; Brant, Roz; Hodgson, Darren Richard; Sharpe, Alan; Smith, Paul; Cutts, Anthony; Schuh, Anna; Asher, Ruth; Myers, Kevin; Love, Sharon; Collins, Linda; Wise, Adelyn; Middleton, Mark Roy; Macaulay, Valentine Moya Share Save
Reassessment of Routine Midstream Culture in Diagnosis of Urinary Tract Infection Sathiananthamoorthy, Sanchutha; Malone-Lee, James; Gill, Kiren; Tymon, Anna; Nguyen, Trang K.; Gurung, Shradha; Collins, Linda; Kupelian, Anthony S.; Swamy, Sheela; Khasriya, Rajvinder; Spratt, David A.; Rohn, Jennifer L. Share Save
RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt Gupta, Avinash; Roberts, Corran; Tysoe, Finn; Goff, Matthew; Nobes, Jenny; Lester, James; Marshall, Ernie; Corner, Carie; Wolstenholme, Virginia; Kelly, Charles; Wise, Adelyn; Collins, Linda; Love, Sharon; Woodward, Martha; Salisbury, Amanda; Middleton, Mark R. Share Save
Comparative Effectiveness of a Burnout Reduction Intervention for Behavioral Health Providers Rollins, Angela L.; Kukla, Marina; Morse, Gary; Davis, Louanne; Leiter, Michael; Monroe-DeVita, Maria; Flanagan, Mindy E.; Russ, Alissa; Wasmuth, Sara; Eliacin, Johanne; Collins, Linda; Salyers, Michelle P. Share Save
PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel Coupe, Nicholas; Corrie, Pippa; Hategan, Mirela; Larkin, James; Gore, Martin; Gupta, Avinash; Wise, Adelyn; Suter, Sam; Ciria, Cristian; Love, Sharon; Collins, Linda; Middleton, Mark R. Share Save
A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol Nicum, Shibani; Roberts, Corran; Boyle, Lucy; Kopijasz, Sylwia; Gourley, Charlie; Hall, Marcia; Montes, Ana; Poole, Christopher; Collins, Linda; Schuh, Anna; Dutton, Susan J. Share Save
Consumer and Relationship Factors Associated With Shared Decision Making in Mental Health Consultations Matthias, Marianne S.; Fukui, Sadaaki; Kukla, Marina; Eliacin, Johanne; Bonfils, Kelsey A.; Firmin, Ruth L.; Oles, Sylwia K.; Adams, Erin L.; Collins, Linda A.; Salyers, Michelle P. Share Save
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma Gupta, A.; Love, S.; Schuh, A.; Shanyinde, M.; Larkin, J. M.; Plummer, R.; Nathan, P. D.; Danson, S.; Ottensmeier, C. H.; Lorigan, P.; Collins, L.; Wise, A.; Asher, R.; Lisle, R.; Middleton, M. R. Share Save
Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
